2020 VIRTUAL CMC PANEL DISCUSSION N-NITROSAMINE IMPURITY CONTROL STRATEGIES IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
AAPS CMC Community
DATE: DECEMBER 9th, 2020
TIME: 8 AM – 9:30 AM PST (10 AM CST/11 AM EST)
PARTICIPANT NUMBER LIMITED TO 250
Please join us for an engaging panel discussion on N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology Industries: Challenges and Progress.
The following experts will share their experiences and views on this topic:
• Andrew Lennard (Amgen)
• Mohan Ganapathy (Merck)
• FDA – Panel Speaker to Be Determined
• FDA – Panel Speaker to Be Determined